183 related articles for article (PubMed ID: 34467531)
1. A novel method for office aspiration curettage in cases of retained products of conception: A randomized controlled trial.
Pomeranz M; Goren Gepstein N; Ovadia M; Klein Z; Daykan Y; Schonman R; Arbib N
Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2076-2081. PubMed ID: 34467531
[TBL] [Abstract][Full Text] [Related]
2. Hysteroscopic morcellation vs. curettage for removal of retained products of conception: a multicenter randomized controlled trial.
Wagenaar LP; Hamerlynck TW; Radder CM; Peters LW; Weyers S; Schoot BC; van Vliet HA
Fertil Steril; 2023 Dec; 120(6):1243-1251. PubMed ID: 37657600
[TBL] [Abstract][Full Text] [Related]
3. Retained products of conception: What is the risk for recurrence on subsequent pregnancies?
Smorgick N; Mittler A; Ben-Ami I; Maymon R; Vaknin Z; Pansky M
Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():1-5. PubMed ID: 29525517
[TBL] [Abstract][Full Text] [Related]
4. Office Operative Hysteroscopy for the Management of Retained Products of Conception.
Mohr-Sasson A; Gur T; Meyer R; Mashiach R; Stockheim D
Reprod Sci; 2022 Mar; 29(3):761-767. PubMed ID: 35020188
[TBL] [Abstract][Full Text] [Related]
5. Sublingual misoprostol after surgical management of early termination of pregnancy.
Mulayim B; Celik NY; Onalan G; Zeyneloglu HB; Kuscu E
Fertil Steril; 2009 Aug; 92(2):678-81. PubMed ID: 18774567
[TBL] [Abstract][Full Text] [Related]
6. Office hysteroscopy in removing retained products of conception - a highly successful approach with minimal complications.
Jakopič Maček K; Blaganje M; Kenda Šuster N; Drusany Starič K; Kobal B
J Obstet Gynaecol; 2020 Nov; 40(8):1122-1126. PubMed ID: 31793362
[TBL] [Abstract][Full Text] [Related]
7. Outcome of using vaginal misoprostol for treatment of retained products of conception after first trimester miscarriage: a retrospective cohort study.
Stewart KT; Lee JS; Pan K; Albert AY; Fisher S
Eur J Contracept Reprod Health Care; 2020 Dec; 25(6):474-479. PubMed ID: 32869658
[TBL] [Abstract][Full Text] [Related]
8. Hysteroscopy-assisted suction curettage for early pregnancy loss: does it reduce retained products of conception and postoperative intrauterine adhesions?
Moore O; Tzur T; Vaknin Z; Rabbi ML; Smorgick N
Arch Gynecol Obstet; 2024 Jan; 309(1):205-210. PubMed ID: 37782418
[TBL] [Abstract][Full Text] [Related]
9. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue.
Nielsen S; Hahlin M; Platz-Christensen JJ
Br J Obstet Gynaecol; 1997 Sep; 104(9):1094-6. PubMed ID: 9307543
[TBL] [Abstract][Full Text] [Related]
10. A medical approach to management of spontaneous abortion using misoprostol. Extending misoprostol treatment to a maximum of 48 hours can further improve evacuation of retained products of conception in spontaneous abortion.
Chung T; Leung P; Cheung LP; Haines C; Chang AM
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):248-51. PubMed ID: 9093140
[TBL] [Abstract][Full Text] [Related]
11. Complications of first-trimester abortion by vacuum aspiration after cervical preparation with and without misoprostol: a multicentre randomised trial.
Meirik O; My Huong NT; Piaggio G; Bergel E; von Hertzen H;
Lancet; 2012 May; 379(9828):1817-24. PubMed ID: 22405255
[TBL] [Abstract][Full Text] [Related]
12. [Assessment of efficacy and safety of medical treatment of non-viable first trimester pregnancy].
Zwierzchowska A; Głuszak M; Jabiry-Zieniewicz Z; Banaszek-Wysoczańska A; Dziadecki W; Barcz E
Ginekol Pol; 2012 Oct; 83(10):760-5. PubMed ID: 23383562
[TBL] [Abstract][Full Text] [Related]
13. Transvaginal ultrasound after first-trimester uterine evacuation reduces the incidence of retained products of conception.
Debby A; Malinger G; Harow E; Golan A; Glezerman M
Ultrasound Obstet Gynecol; 2006 Jan; 27(1):61-64. PubMed ID: 16374763
[TBL] [Abstract][Full Text] [Related]
14. Operative hysteroscopy versus ultrasound-guided electric vacuum aspiration for removal of retained products of conception: A prospective cohort study.
Wagenaar LP; van Vliet HA; Radder CM; Peters LW; Weyers S; Schoot BC; Hamerlynck TW
Eur J Obstet Gynecol Reprod Biol X; 2023 Dec; 20():100230. PubMed ID: 37701632
[TBL] [Abstract][Full Text] [Related]
15. Hysteroscopic removal of retained products of conception following first trimester medical abortion.
Smorgick N; Levinsohn-Tavor O; Ben-Ami I; Maymon R; Pansky M; Vaknin Z
Gynecol Minim Invasive Ther; 2017; 6(4):183-185. PubMed ID: 30254910
[TBL] [Abstract][Full Text] [Related]
16. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure.
Stockheim D; Machtinger R; Wiser A; Dulitzky M; Soriano D; Goldenberg M; Schiff E; Seidman DS
Fertil Steril; 2006 Oct; 86(4):956-60. PubMed ID: 17027362
[TBL] [Abstract][Full Text] [Related]
17. Oral misoprostol for cervical priming in non-pregnant women.
Ngai SW; Chan YM; Liu KL; Ho PC
Hum Reprod; 1997 Nov; 12(11):2373-5. PubMed ID: 9436666
[TBL] [Abstract][Full Text] [Related]
18. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion.
Weeks A; Alia G; Blum J; Winikoff B; Ekwaru P; Durocher J; Mirembe F
Obstet Gynecol; 2005 Sep; 106(3):540-7. PubMed ID: 16135584
[TBL] [Abstract][Full Text] [Related]
19. Expectant vs medical management for retained products of conception after medical termination of pregnancy: a randomized controlled study.
Tzur Y; Berkovitz-Shperling R; Goitein Inbar T; Bar-On S; Gil Y; Levin I; Cohen A
Am J Obstet Gynecol; 2022 Oct; 227(4):599.e1-599.e9. PubMed ID: 35752301
[TBL] [Abstract][Full Text] [Related]
20. Postpartum retained products of conception: Retrospective analysis of the association with third stage of labor placental complications.
Smorgick N; Ayashi N; Levinsohn-Tavor O; Wiener Y; Betser M; Maymon R
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():108-111. PubMed ID: 30682599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
